Castle Biosciences CSTL
NASDAQ CSTL
$34.74 -0.25 (-0.70%)
As of: Sep 22, 2026 · 10:48 AM EDT

Castle Biosciences (CSTL) Net Income towards Common Stockholders Growth (5y) (2023 - 2026)

Analysis

Castle Biosciences (CSTL) Net Income towards Common Stockholders Growth (5y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Castle Biosciences 1.08 Bn 811.36 Mn 79.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.19%
Mar 31, 2026 -27.68%
Dec 31, 2025 13.76%
Sep 30, 2025 35.79%
Jun 30, 2025 39.65%
Mar 31, 2025 -116.30%
Dec 31, 2024 36.08%
Sep 30, 2024 -16.36%
Jun 30, 2024 42.80%
Mar 31, 2024 -1.59%
Dec 31, 2023 -23.74%
Sep 30, 2023 -9.16%
Jun 30, 2023 -35.70%
API Access

Castle Biosciences Net Income towards Common Stockholders Growth (5y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders-growth-5y&ticker=CSTL&period=max&api_key=YOUR_API_KEY